
BioAtla
(NASDAQ) BCAB
BioAtla Financials at a Glance
Market Cap
$9.68M
Revenue (TTM)
$2.00M
Net Income (TTM)
$59.61M
EPS (TTM)
$-1.02
P/E Ratio
-0.13
Dividend
$0.00
Beta (Volatility)
1.74 (High)
Dividend
$0.00
Beta (Volatility)
1.74 (High)
Price
$0.13
Volume
7,573
Open
$0.13
Price
$0.13
Volume
7,573
Open
$0.13
Previous Close
$0.13
Daily Range
$0.13 - $0.14
52-Week Range
$0.12 - $1.43
Dividend
$0.00
Beta (Volatility)
1.74 (High)
Price
$0.13
Volume
7,573
Open
$0.13
Previous Close
$0.13
Daily Range
$0.13 - $0.14
52-Week Range
$0.12 - $1.43
BCAB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioAtla
Industry
Biotechnology
Sector
Health CareEmployees
41
CEO
Jay M. Short, PhD
Website
www.BioAtla.comHeadquarters
San Diego, CA 92121, US
BCAB Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-30%
Net Income Margin
-30%
Return on Equity
-814%
Return on Capital
7%
Return on Assets
-4%
Earnings Yield
-7.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.68M
Shares Outstanding
74.26M
Volume
7.57K
Short Interest
0.00%
Avg. Volume
2.30M
Financials (TTM)
Gross Profit
$2.00M
Operating Income
$59.30M
EBITDA
$58.93M
Operating Cash Flow
$48.20M
Capital Expenditure
$0.00
Free Cash Flow
$48.20M
Cash & ST Invst.
$7.12M
Total Debt
$6.20M
BioAtla Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.00M
N/A
Gross Profit
$2.81M
+124.1%
Gross Margin
1.40%
N/A
Market Cap
$9.68M
N/A
Market Cap/Employee
$158.75K
N/A
Employees
61
N/A
Net Income
$9.78M
+34.3%
EBITDA
$7.62M
+52.4%
Quarterly Fundamentals
Net Cash
$918.00K
-98.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$4.77M
N/A
Short Term Debt
$1.43M
+70.7%
Return on Assets
-4.31%
N/A
Return on Invested Capital
7.33%
N/A
Free Cash Flow
$7.92M
+52.8%
Operating Cash Flow
$7.92M
+52.8%
